{
    "Trade/Device Name(s)": [
        "Eu-tTG\u00ae IgA",
        "Eu-tTG\u00ae IgG"
    ],
    "Submitter Information": "Grifols USA, LLC",
    "510(k) Number": "K102964",
    "Predicate Device Reference 510(k) Number(s)": [
        "K010625",
        "K042644"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MVM"
    ],
    "Summary Letter Date": "February 7, 2011",
    "Summary Letter Received Date": "February 8, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5660"
    ],
    "Regulation Name(s)": [
        "Multiple autoantibodies immunological test system"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology",
        "serology"
    ],
    "Analyte(s)": [
        "IgA anti-tissue transglutaminase antibodies",
        "IgG anti-tissue transglutaminase antibodies"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "Microtiter plate (12 strips, 8 microwells coated with recombinant tTG antigen)"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "ELISA"
    ],
    "Methodologies": [
        "Enzyme-linked immunosorbent assay (ELISA)",
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Kit",
        "Calibrator",
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Grifols Eu-tTG\u00ae IgA and IgG enzyme immunoassay kits for detection of anti-tissue transglutaminase antibodies as an aid in the diagnosis of celiac disease",
    "Indications for Use Summary": "In vitro diagnostic enzyme immunoassays for the semi-quantitative detection of IgA or IgG antibodies against tissue transglutaminase (tTG) in human serum as an aid in the diagnosis of celiac disease, for use with other serological tests and clinical findings.",
    "fda_folder": "Immunology"
}